SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunomedics (IMMU) - moderated
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: idahoranch1 who wrote (56128)5/3/2020 10:51:04 AM
From: CPark6 Recommendations

Recommended By
bobbseytwins2001
idahoranch1
jargonweary
Renmanco
summer_sky

and 1 more member

   of 63276
 
Thank you, Idaho, this is quite helpful. Since these trials are open label (no masking whatsoever), including Tropics-02, the company and the lead investigator should have a good idea of the results. In this regard, it's very encouraging that Behzad's fund bought 50 million dollars in the latest raise. They are the 'house' with foreknowledge of how the cards will fall, and they're going pretty much 'all in.' I'd think it's a good idea to follow along.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News